PROSPECTIVE CONTROLLED TRIAL OF SCLEROTHERAPY IN THE LONG-TERM MANAGEMENT OF PATIENTS AFTER ESOPHAGEAL VARICEAL BLEEDING

Authors:
  • JTJ Terblanche
    J Terblanche
  • JNJ M Northover
    J M Northover
  • PBP Bornman
    P Bornman
  • DKD Kahn
    D Kahn
  • WSW Silber
    W Silber
  • GBG O Barbezat
    G O Barbezat
  • SSS Sellars
    S Sellars
  • JCJ A Campbell
    J A Campbell
  • SSS J Saunders
    S J Saunders

  • 1 January 1979
    • journal article
    • research article
    • Vol. 148  (3) , 323-333
    • PMID:369006
Abstract
Results of the first 25 mo. of a prospective clinical trial to compare repeated injection sclerotherapy with conservative medical management in long term treatment of patients who previously bled from esophageal varices, are presented. Of 31 patients, 15 were in the chronic injection group, 16 were in the control medical management group and 5 patients excluded for geographic reasons were injected out of trial. Ethanolamine oleate was injected into the varices, using a modified rigid esophagoscope under general anesthesia. Preliminary results were encouraging. Esophageal varices were eradicated in the chronic injection group, and no patient had recurrence of variceal bleeding. Variceal bleeding recurred in control patients. A longer follow-up period is required to assess the quantitative and qualitative aspects and survival and to determine how long esophageal varices remain eradicated and how frequently repeated injections are required.

This publication has 3 references indexed in Scilit: